These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28728199)

  • 1. [Polypharmacy - Solutions for Enhanced Drug Safety].
    Krause O; Picksak G; Junius-Walker U
    Dtsch Med Wochenschr; 2017 Jul; 142(14):1046-1053. PubMed ID: 28728199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification.
    Wehling M; Burkhardt H; Kuhn-Thiel A; Pazan F; Throm C; Weiss C; Frohnhofen H
    Age Ageing; 2016 Mar; 45(2):262-7. PubMed ID: 26786346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric Polypharmacy: Pharmacist as Key Facilitator in Assessing for Falls Risk: 2019 Update.
    Fritsch MA; Shelton PS
    Clin Geriatr Med; 2019 May; 35(2):185-204. PubMed ID: 30929882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for reducing polypharmacy in older adults.
    Planton J; Edlund BJ
    J Gerontol Nurs; 2010 Jan; 36(1):8-12. PubMed ID: 20047247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-drug interactions in the elderly : Which ones really matter?].
    Bitter K; Schlender JF; Woltersdorf R
    Internist (Berl); 2016 Jul; 57(7):728-34. PubMed ID: 27294383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany.
    Cortejoso L; Dietz RA; Hofmann G; Gosch M; Sattler A
    Clin Interv Aging; 2016; 11():1343-1350. PubMed ID: 27713625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric Polypharmacy: Pharmacist as Key Facilitator in Assessing for Falls Risk.
    Fritsch MA; Shelton PS
    Clin Geriatr Med; 2017 May; 33(2):205-223. PubMed ID: 28364992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of polypharmacy among older primary care patients in Germany.
    Junius-Walker U; Theile G; Hummers-Pradier E
    Fam Pract; 2007 Feb; 24(1):14-9. PubMed ID: 17164234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. District nurses' use of a decision support and assessment tool to improve the quality and safety of medication use in older adults: a feasibility study.
    Lagerin A; Lundh L; Törnkvist L; Fastbom J
    Prim Health Care Res Dev; 2020 Jun; 21():e15. PubMed ID: 32495732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population.
    Leendertse AJ; de Koning GH; Goudswaard AN; Belitser SV; Verhoef M; de Gier HJ; Egberts AC; van den Bemt PM
    J Clin Pharm Ther; 2013 Oct; 38(5):379-87. PubMed ID: 23617687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments.
    Pazan F; Burkhardt H; Frohnhofen H; Weiss C; Throm C; Kuhn-Thiel A; Wehling M
    Eur J Clin Pharmacol; 2018 Mar; 74(3):339-347. PubMed ID: 29196825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polypharmacy and multiple uses of medical facilities in nursing home residents.
    Kojima T; Shimada K; Terada A; Nishizawa K; Matsumoto K; Yoshimatsu Y; Akishita M
    Geriatr Gerontol Int; 2016 Jun; 16(6):770-1. PubMed ID: 27246580
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Patient's Last Wish at the End-of-Life.
    Cimmino K; Pisano M
    Consult Pharm; 2016 Jul; 31(7):375-80. PubMed ID: 27412313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decision aids in complex polypharmacy : Medication data bases and counselling by clinical pharmacists].
    Weinrebe W; Preda R; Bischoff S; Nussbickel D; Humm M; Jeckelmann K; Goetz S
    Z Gerontol Geriatr; 2018 Aug; 51(6):691-697. PubMed ID: 28721543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information on actual medication use and drug-related problems in older patients: questionnaire or interview?
    Willeboordse F; Grundeken LH; van den Eijkel LP; Schellevis FG; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Apr; 38(2):380-7. PubMed ID: 26830412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse drug reactions in the elderly: What dermatologists should know].
    Kratzsch D; Simon JC; Treudler R
    Hautarzt; 2016 Feb; 67(2):125-31. PubMed ID: 26643292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy in the elderly: maximizing benefit, minimizing harm.
    Ballentine NH
    Crit Care Nurs Q; 2008; 31(1):40-5. PubMed ID: 18316935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.